West Nile virus lineage 2 as a cause of zoonotic neurological disease in humans and horses in Southern Africa

Vector-Borne and Zoonotic Diseases

Volumn 10, Issue 7, 2010, Pages 659-664

  Venter, Marietjie ^a,b   Swanepoel, Robert ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

Cytokines; Lineage 2; Neurological disease; West Nile Virus; Zoonosis

Indexed keywords

CYTOKINE; VIRUS DNA; WEST NILE VACCINE;

AFRICA; AUTOPSY; BRAIN INFECTION; DISEASE SEVERITY; DNA SEQUENCE; ENCEPHALOMYELITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EPIDEMIOLOGICAL DATA; EUTHANASIA; FEVER; GENE EXPRESSION; GENE SEQUENCE; HORSE; HUMAN; IMMUNOPATHOGENESIS; LABORATORY INFECTION; MORTALITY; NEEDLESTICK INJURY; NEUROLOGIC DISEASE; NONHUMAN; OCCUPATIONAL DISEASE; PATHOGENESIS; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEROCONVERSION; SEROLOGY; VETERINARY MEDICINE; VIRUS ENCEPHALITIS; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; WEST NILE FEVER; WEST NILE FLAVIVIRUS; ZOONOSIS;

ANIMALS; FEMALE; HORSE DISEASES; HORSES; HUMANS; MALE; MICE; NEEDLESTICK INJURIES; SOUTH AFRICA; VIRULENCE; WEST NILE FEVER; WEST NILE VIRUS; ZOONOSES;

CANIS FAMILIARIS; EQUIDAE; STRUTHIONIFORMES; WEST NILE VIRUS;

EID: 77957567348     PISSN: 15303667     EISSN: None     Source Type: Journal    
DOI: 10.1089/vbz.2009.0230     Document Type: Review

References (46)

1. Bakonyi, T, Hubalek, Z, Rudolf, I, Nowotny, N. Novel flavivirus or new lineage of West Nile virus, central Europe. Emerg Infect Dis 2005; 11:225-231.
2. Bakonyi, T, Ivanics, E, Erdelyi, K, Ursu, K, et al. Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe. Emerg Infect Dis 2006; 12:618-623.
3. Beasley, DW. Recent advances in the molecular biology of West Nile virus. Curr Mol Med 2005; 5:835-850.
4. Beasley, DW, Li, L, Suderman, MT, Barrett, AD. Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 2002; 296:17-23.
5. Beasley, DW, Li, L, Suderman, MT, Barrett, AD. West Nile virus strains differ in mouse neurovirulence and binding to mouse or human brain membrane receptor preparations. Ann N Y Acad Sci 2001; 951:332-335.
6. Beasley, DW, Whiteman, MC, Zhang, S, Huang, CY, et al. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J Virol 2005; 79:8339-8347.
7. Bondre, VP, Jadi, RS, Mishra, AC, Yergolkar, PN, et al. West Nile virus isolates from India: evidence for a distinct genetic lineage. J Gen Virol 2007; 88(PART 3):875-884.
8. Botha, EM, Markotter, W, Wolfaardt, M, Paweska, JT, et al. Genetic determinants of virulence in pathogenic lineage 2 West Nile virus strains. Emerg Infect Dis 2008; 14:222-230.
9. Bunning, ML, Bowen, RA, Cropp, CB, Sullivan, KG, et al. Experimental infection of horses with West Nile virus. Emerg Infect Dis 2002; 8:380-386.
10. Burt, FJ, Grobbelaar, AA, Leman, PA, Anthony, FS, et al. Phylogenetic relationships of southern African West Nile virus isolates. Emerg Infect Dis 2002; 8:820-826.
11. Cantile, C, Del Piero, F, Di Guardo, G, Arispici, M. Pathologic and immunohistochemical findings in naturally occurring West Nile virus infection in horses. Vet Pathol 2001; 38:414-421.
12. Dauphin, G, Zientara, S. West Nile virus: recent trends in diagnosis and vaccine development. Vaccine 2007; 25:5563-5576.
13. Dauphin, G, Zientara, S, Zeller, H, Murgue, B. West Nile: worldwide current situation in animals and humans. Comp Immunol Microbiol Infect Dis 2004; 27:343-355.
14. Durand, B, Chevalier, V, Pouillot, R, Labie, J, et al. West Nile virus outbreak in horses, southern France, 2000: results of a serosurvey. Emerg Infect Dis 2002; 8:777-782.
15. Durand, JP, Simon, F, Tolou, H. [West Nile virus: in France again, in humans and horses]. Rev Prat 2004; 54:703-710.
16. Erdelyi, K, Ursu, K, Ferenczi, E, Szeredi, L, et al. Clinical and pathologic features of lineage 2 West Nile virus infections in birds of prey in Hungary. Vector Borne Zoonot Dis 2007; 7:181-188.
17. Guthrie, AJ, Howell, PG, Gardner, IA, Swanepoel, RE, et al. West Nile virus infection of Thoroughbred horses in South Africa (2000-2001). Equine Vet J 2003; 35:601-605.
18. Hayes, EB, Gubler, DJ. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu Rev Med 2006; 57:181-194.
19. Hayes, EB, Sejvar, JJ, Zaki, SR, Lanciotti, RS, et al. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis 2005; 11:1174-1179.
20. Jupp, PG. The ecology of West Nile virus in South Africa and the occurrence of outbreaks in humans. Ann N Y Acad Sci 2001; 951:143-152.
21. Kalil, AC, Devetten, MP, Singh, S, Lesiak, B, et al Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases. Clin Infect Dis 2005; 40:764-766.
22. Kinney, R, Huang, C-H, Whiteman, M, Bowen, R, et al. Avain virulence and thermostable replication of the North American strain of West Nile virus. J Gen Virol 2006; 87:3611-3622.
23. Lanciotti, RS, Ebel, GD, Deubel, V, Kerst, AJ, et al. Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology 2002; 298:96-105.
24. Lanciotti, RS, Roehrig, JT, Deubel, V, Smith, J, et al Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999; 286:2333-2337.
25. Lvov, DK, Butenko, AM, Gromashevsky, VL, Kovtunov, AI, et al. West Nile virus and other zoonotic viruses in Russia: examples of emerging-reemerging situations. Arch Virol Suppl 2004; (18):85-96.
26. McIntosh, B (1980). The epidemiology of arthropod-borne viruses in southern Africa. University of Pretoria, Pretoria, South Africa.
27. McIntosh, B, Jupp, P, Dos Santos, I, Meenehan, G. Epidemics of West Nile and Sindbis viruses in South Africa and Culex (Culex) univittatus. S Afr J Sci 1976; 72:295-300.
28. Murgue, B, Murri, S, Zientara, S, Durand, B, et al. West Nile outbreak in horses in southern France, 2000: the return after 35 years. Emerg Infect Dis 2001; 7:692-696.
29. Nielsen, CF, Reisen, WK, Armijos, MV, Maclachlan, NJ, et al. High subclinical West Nile virus incidence among non-vaccinated horses in northern California associated with low vector abundance and infection. Am J Trop Med Hyg 2008; 78:45-52.
30. Ostlund, EN, Crom, RL, Pedersen, DD, Johnson, DJ, et al. Equine West Nile Encephalitis, United States. Emerg Infect Dis 2001; 7:665-660.
31. Petersen, LR, Marfin, AA. West Nile virus: a primer for the clinician. Ann Intern Med 2002; 137:173-179.
32. Puig-Basagoiti, F, Tilgner, M, Bennett, C, Yangsheng, Z, et al. A mouse cell-adapted NS4B mutation attenuates West Nile virus RNA synthesis. Virology 2007; 361:229-241.
33. Schuler, LA, Khaitsa, ML, Dyer, NW, Stoltenow, CL. Evaluation of an outbreak of West Nile virus infection in horses: 569 cases (2002). J Am Vet Med Assoc 2004; 225:1084-1089.
34. Smithburn, K, Huges, T, Burke, A, Paul, J. A neurotropic virus isolated from the blood of a native Uganda. Am J Trop Med Hyg 1940; 20:471-492.
35. Steinman, A, Banet, C, Sutton, GA, Yadin, H, et al. Clinical signs of West Nile virus encephalomyelitis in horses during the outbreak in Israel in 2000. Vet Rec 2002; 151:47-49.
36. Tesh, RB, Travassos da Rosa, AP, Guzman, H, Araujo, TP, et al. Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis. Emerg Infect Dis 2002; 8:245-251.
37. Van Der Poel, WH. [West Nile-like virus is the cause of encephalitis in humans and horses and the death of hundreds of birds in New York]. Tijdschr Diergeneeskd 1999; 124: 704-705.
38. Venter, M, Burt, FJ, Blumberg, L, Fickl, H, et al. Cytokine induction after laboratory-acquired West Nile virus infection. N Engl J Med 2009a; 360:1260-1262.
39. Venter, M, Human, S, Zaayman, D, Gerdes, GH, et al. Lineage 2 West Nile virus as cause of fatal neurologic disease in horses, South Africa. Emerg Infect Dis 2009b; 15:877-884.
40. Venter, M, Myers, TG, Wilson, MA, Kindt, TJ, et al. Gene expression in mice infected with West Nile virus strains of different neurovirulence. Virology 2005; 342:119-140.
41. Venter, M, Steyl, J, Human, S, Weyer, J, et al. Transmission of West Nile virus during horse autopsy. Emerg Infect Dis 2010; 16:573-575.
42. Ward, MP, Levy, M, Thacker, HL, Ash, M, et al. Investigation of an outbreak of encephalomyelitis caused by West Nile virus in 136 horses. J Am Vet Med Assoc 2004; 225:84-89.
43. Ward, MP, Schuermann, JA, Highfield, LD, Murray, K. Characteristics of an outbreak 255 of West Nile virus encephalo-myelitis in a previously uninfected population of horses. Vet Microbiol 2006; 118:225-229.
44. Wicker, JA, Whiteman, MC, Beasley, DW, Davis, CT, et al. A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. Virology 2006; 349:245-253.
45. Yamshchikov, G, Borisevich, V, Kwok, CW, Nistler, R, et al. The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus. Vaccine 2005; 23:4785-4792.
46. Yamshchikov, G, Borisevich, V, Seregin, A, Chaporgina, E, et al. An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development. Virology 2004; 330:304-312.